You are here : Home > Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti-Tumor Necrosis Factor Treatments in Rheumatoid Arthritis

Publications CNRGH

Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti-Tumor Necrosis Factor Treatments in Rheumatoid Arthritis

Published on 2 October 2023
Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti-Tumor Necrosis Factor Treatments in Rheumatoid Arthritis
Description
 
Date de publication 
Auteurs
Santinon F, Batignes M, Mebrek ML, Biton JM, Clavel G, Herve R, Lemeiter D, Breckler M, Busato F, Tost J, Ziol M, Boissier MC, Decker P, Semerano L and Bessis N
Revue
Année2,020
Département / Service
CNRGH
Laboratoire
LEE
Impact Factor 
InstitutJACOB
url DOI10.1002/art.41134

Retour à la liste